SI-BONE Inc (SIBN)

• Market cap: $556M
• 1 day: 1.53%
• 5 days: -0.82%
• 1 month: 9.05%
• 3 months: -13.91%
• 6 months: 8.52%
• Year to date: -36.42%
• 1 year: -35.21%
• 5 years: -34.57%
• 10 years: -33.95%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Employees: 344

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

41% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 37

6% more capital invested

Capital invested by funds: $535M [Q2] → $569M (+$34.3M) [Q3]

6% more call options, than puts

Call options by funds: $3.72M | Put options by funds: $3.52M

2.71% less ownership

Funds ownership: 100.37% [Q2] → 97.66% (-2.71%) [Q3]

3% less funds holding

Funds holding: 137 [Q2] → 133 (-4) [Q3]

16% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 25

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $18 36% upside
• Avg. target: $18.50 40% upside
• High target: $19 43% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Needham David Saxon 25% 1-year accuracy 15 / 61 met price target	43% upside $19	Buy Reiterated	20 Nov 2024
Truist Securities Samuel Brodovsky 87% 1-year accuracy 13 / 15 met price target	36% upside $18	Buy Maintained	13 Nov 2024